| Title: |
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial |
| Authors: |
Paz-Ares, L; Spira, A; Raben, D; Planchard, D; Cho, BC; Ozguroglu, M; Daniel, D; Villegas, A; Vicente, D; Hui, R; Murakami, S; Spigel, D; Senan, S; Langer, CJ; Boothman, AM; Broadhurst, H; Wadsworth, C; Dennis, PA; Antonia, SJ; Faivre-Finn, Corinne |
| Contributors: |
Hospital Universitario 12 de Octubre, Lung Cancer Unit CNIO-H12o, CiberOnc and Universidad Complutense, Madrid, Spain |
| Publication Year: |
2020 |
| Collection: |
The Christie School of Oncology: Christie Research Publications Repository |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
https://dx.doi.org/10.1016/j.annonc.2020.03.287; http://hdl.handle.net/10541/622912; Annals of Oncology |
| DOI: |
10.1016/j.annonc.2020.03.287 |
| Availability: |
http://hdl.handle.net/10541/622912; https://doi.org/10.1016/j.annonc.2020.03.287 |
| Accession Number: |
edsbas.B778F7FC |
| Database: |
BASE |